Covid-19 roundup: Moderna adds vaccine experts as PhIII trial looms; Feng Zhang group snags instant OK on CRISPR-based test
Moderna has expanded its top executive team as it confirms its timeline on a hectic race to the finish line for one of the leading …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
